Pictet Asset Management (Switzerland)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$176M Buy
350,244
+69,780
+25% +$33.4M 0.21% 127
2023
Q1
$140M Buy
280,464
+10,883
+4% +$5.21M 0.18% 160
2022
Q4
$110M Sell
269,581
-36,551
-12% -$14.2M 0.16% 175
2022
Q3
$102M Sell
306,132
-23,532
-7% -$8.64M 0.15% 185
2022
Q2
$116M Buy
329,664
+24,053
+8% +$9.81M 0.16% 178
2022
Q1
$167M Buy
305,611
+56,061
+22% +$29.5M 0.19% 158
2021
Q4
$164M Buy
249,550
+17,423
+8% +$10.9M 0.16% 169
2021
Q3
$144M Buy
+232,127
New +$156M 0.16% 171

Other funds holding IDXX

Pictet Asset Management (Switzerland)'s IDXX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Idexx Laboratories (IDXX) stake by 25% in Q2 2023, buying an estimated $33.4M and bringing the position to 350,244 shares worth $176M. The position accounts for 0.21% of the portfolio, ranked #127.

Pictet Asset Management (Switzerland) first reported a position in IDXX in Q3 2021 and has held it in 8 quarters since. 1,069 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 350,244 shares of Idexx Laboratories worth $176M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 69,780 Idexx Laboratories shares in Q2 2023, an estimated $33.4M.
  • Idexx Laboratories made up 0.21% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #127 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Idexx Laboratories in Q3 2021 and has held it in 8 quarters since.
  • 1,069 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.